A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression

Medicine and Dentistry

• Lamotrigine 100%
• Placebo 80%
• Depression 40%
• Monotherapy 40%
• Bipolar I Disorder 30%
• Therapeutic Procedure 30%
• Outpatient 20%
• Antidepressant 20%
• Montgomery-Åsberg Depression Rating Scale 20%
• Clinical Global Impression 20%
• Bipolar Depression 20%
• Group Therapy 10%
• Rating Scale 10%
• Headache 10%
• Adverse Event 10%
• Major Depressive Episode 10%
• Bipolar Disorder 10%
• Hamilton Rating Scale for Depression 10%
• DSM-IV 10%
• Anticonvulsant 10%
• Placebo-Controlled Study 10%
• Mood Stabilizer 10%
• Evaluation Study 10%
• Patient 10%
• Cycling 10%
• Amaurosis 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Lamictal 100%
• Depression 40%
• Monotherapy 40%
• Bipolar I Disorder 30%
• Bipolar Depression 20%
• Adverse Event 10%
• Anticonvulsive Agent 10%
• Placebo-Controlled Study 10%
• Major Depression 10%
• Mood Stabilizer 10%
• DSM-IV 10%
• Bipolar Disorder 10%
• Headache 10%
• Blindness 10%